How OSTHUS reduced risk in vaccine manufacturing by 6%
Every year, new strains of influenza viruses cause hospitalizations, deaths, and economic hardship worldwide. Though vaccines are effective at combating epidemics, the genetic makeup of influenza viruses continuously change, requiring consistent vaccine updates ...
How to accelerate time-to-market with a hybrid cloud architecture
To reach their goal of transforming the Biopharma industry, AstraZeneca requested an architecture that could support streamlined data and analytics across ...
Typical R&D firms have gradually begun to realize that a robust Data Governance mechanism far outweighs the cost curtailing or controlling measures in short term. Regulatory environment under GxP has become ...
